This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cherikh WS et al. (2003) Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 76: 1289–1293
Rasul I et al. (1999) Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 29: 543–547
Faull RJ et al. (2005) Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation 80: 193–197
Davis CL (1998) The antiviral prophylaxis of post-transplant lymphoproliferative disease. Springer Semin Immunopathol 20: 437–453
McDiarmid SV et al. (1998) Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 66: 1604–1611
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Buell, J. Antiviral prophylaxis for the prevention of post-transplantation lymphoproliferative disorder. Nat Rev Nephrol 2, 420–421 (2006). https://doi.org/10.1038/ncpneph0242
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ncpneph0242